173 related articles for article (PubMed ID: 27788955)
1. Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy.
Dean JA; Wong KH; Gay H; Welsh LC; Jones AB; Schick U; Oh JH; Apte A; Newbold KL; Bhide SA; Harrington KJ; Deasy JO; Nutting CM; Gulliford SL
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):820-831. PubMed ID: 27788955
[TBL] [Abstract][Full Text] [Related]
2. Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy.
Dean JA; Wong KH; Welsh LC; Jones AB; Schick U; Newbold KL; Bhide SA; Harrington KJ; Nutting CM; Gulliford SL
Radiother Oncol; 2016 Jul; 120(1):21-7. PubMed ID: 27240717
[TBL] [Abstract][Full Text] [Related]
3. Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study.
Deneuve S; Bastogne T; Duclos M; Mirjolet C; Bois P; Bachmann P; Nokovitch L; Roux PE; Girodet D; Poupart M; Zrounba P; Claude L; Ferella L; Iacovelli NA; Foray N; Rancati T; Pereira S
Tumori; 2023 Apr; 109(2):173-185. PubMed ID: 35578746
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.
Otter S; Schick U; Gulliford S; Lal P; Franceschini D; Newbold K; Nutting C; Harrington K; Bhide S
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):507-15. PubMed ID: 26460992
[TBL] [Abstract][Full Text] [Related]
5. Functional data analysis in NTCP modeling: a new method to explore the radiation dose-volume effects.
Benadjaoud MA; Blanchard P; Schwartz B; Champoudry J; Bouaita R; Lefkopoulos D; Deutsch E; Diallo I; Cardot H; de Vathaire F
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):654-63. PubMed ID: 25304951
[TBL] [Abstract][Full Text] [Related]
6. How to reduce radiation-related toxicity in patients with cancer of the head and neck.
Garden AS; Lewin JS; Chambers MS
Curr Oncol Rep; 2006 Mar; 8(2):140-5. PubMed ID: 16507224
[TBL] [Abstract][Full Text] [Related]
7. Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort.
Blanchard P; Wong AJ; Gunn GB; Garden AS; Mohamed ASR; Rosenthal DI; Crutison J; Wu R; Zhang X; Zhu XR; Mohan R; Amin MV; Fuller CD; Frank SJ
Radiother Oncol; 2016 Dec; 121(3):381-386. PubMed ID: 27641784
[TBL] [Abstract][Full Text] [Related]
8. Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk.
Dean JA; Welsh LC; Wong KH; Aleksic A; Dunne E; Islam MR; Patel A; Patel P; Petkar I; Phillips I; Sham J; Schick U; Newbold KL; Bhide SA; Harrington KJ; Nutting CM; Gulliford SL
Clin Oncol (R Coll Radiol); 2017 Apr; 29(4):263-273. PubMed ID: 28057404
[TBL] [Abstract][Full Text] [Related]
9. Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy.
Dean J; Wong K; Gay H; Welsh L; Jones AB; Schick U; Oh JH; Apte A; Newbold K; Bhide S; Harrington K; Deasy J; Nutting C; Gulliford S
Clin Transl Radiat Oncol; 2018 Jan; 8():27-39. PubMed ID: 29399642
[TBL] [Abstract][Full Text] [Related]
10. Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis.
Jakobi A; Bandurska-Luque A; Stützer K; Haase R; Löck S; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1165-1174. PubMed ID: 26194685
[TBL] [Abstract][Full Text] [Related]
11. A new model for predicting acute mucosal toxicity in head-and-neck cancer patients undergoing radiotherapy with altered schedules.
Strigari L; Pedicini P; D'Andrea M; Pinnarò P; Marucci L; Giordano C; Benassi M
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e697-702. PubMed ID: 22578541
[TBL] [Abstract][Full Text] [Related]
12. Radiation-Associated Chronic Dysphagia Assessment by Flexible Endoscopic Evaluation of Swallowing (FEES) in Head and Neck Cancer Patients: Swallowing-Related Structures and Radiation Dose-Volume Effect.
Ozkaya Akagunduz O; Eyigor S; Kirakli E; Tavlayan E; Erdogan Cetin Z; Kara G; Esassolak M
Ann Otol Rhinol Laryngol; 2019 Feb; 128(2):73-84. PubMed ID: 30343589
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.
Antonadou D; Pepelassi M; Synodinou M; Puglisi M; Throuvalas N
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):739-47. PubMed ID: 11849797
[TBL] [Abstract][Full Text] [Related]
14. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy.
Bakhshandeh M; Hashemi B; Mahdavi SR; Nikoofar A; Vasheghani M; Kazemnejad A
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):514-21. PubMed ID: 22583606
[TBL] [Abstract][Full Text] [Related]
15. Statistical validation of normal tissue complication probability models.
Xu CJ; van der Schaaf A; Van't Veld AA; Langendijk JA; Schilstra C
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e123-9. PubMed ID: 22541961
[TBL] [Abstract][Full Text] [Related]
16. Swallowing functional outcomes and nutritional status in head and neck cancer radiotherapy: longitudinal study.
Wang Y; Zhang L; Jin S; Li H; Gong L; Wang Y; Jin S; Cao Y; Shih Y; Lu Q
BMJ Support Palliat Care; 2020 Dec; 10(4):452-461. PubMed ID: 32404303
[TBL] [Abstract][Full Text] [Related]
17. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
Bentzen SM; Saunders MI; Dische S; Bond SJ
Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
[TBL] [Abstract][Full Text] [Related]
19. [The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences].
Dietz A; Nollert J; Maier H; Rudat V; Flentje M
HNO; 1995 Jul; 43(7):403-13. PubMed ID: 7545657
[TBL] [Abstract][Full Text] [Related]
20. Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer.
Bhide SA; Gulliford S; Schick U; Miah A; Zaidi S; Newbold K; Nutting CM; Harrington KJ
Radiother Oncol; 2012 Apr; 103(1):88-91. PubMed ID: 22280809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
